Search Within

Dmitriy Zamarin

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (101)
  2. Meeting Abstract (85)
  3. Editorial (7)
  4. Guidelines (3)
  5. Review (3)
  6. Book Section (2)
Groups
  1. Department of Medicine (201)
  2. GDMT, Medicine (201)
  3. Gynecologic Medicine Service (201)
  4. Gynecology Disease Management Team (201)
  5. Solid Tumor Oncology Division (201)
  6. GSK Faculty (75)

More Groups

People
  1. Carol Aghajanian (60)
  2. Britta Weigelt (50)
  3. Roisin O'Cearbhaill (42)
  4. Claire Friedman (40)
  5. Jedd Wolchok (34)
  6. Nadeem Abu-Rustum (34)

More People

Years
  1. 2024 (8)
  2. 2023 (18)
  3. 2022 (40)
  4. 2021 (16)
  5. 2020 (43)
  6. 2019 (14)

More Years

Publications
  1. Gynecologic Oncology (35)
  2. Journal of Clinical Oncology (24)
  3. Journal for ImmunoTherapy of Cancer (20)
  4. Cancer Research (13)
  5. Clinical Cancer Research (11)
  6. International Journal of Gynecological Cancer (9)

More Publications

Publishers
  1. Elsevier Inc. (37)
  2. American Association for Cancer Research (32)
  3. American Society of Clinical Oncology (29)
  4. Biomed Central Ltd (20)
  5. Nature Publishing Group (20)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (201)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human study of MEDI1191 (mRNA encoding IL-12) plus durvalumab in patients (pts) with advanced solid tumors
    Meeting Abstract

    Carneiro, B. A.; Zamarin, D.; Marron, T.; Mehmi, I.; Patel, S. P.; Subbiah, V.; El-Khoueiry, A.; Grand, D.; Garcia-Reyes, K.; Goel, S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • First-in-human trial of intravenous MEDI9253, an oncolytic virus, in combination with durvalumab in patients with advanced solid tumors
    Meeting Abstract

    Purroy, N.; Durham, N.; Phillips, M.; Hattersley, M. M.; Jung, L.; Davar, D.; Zamarin, D.; Johanns, T. M.; Puzanov, I.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade
    Meeting Abstract

    Muroyama, Y.; Manne, S.; Oldridge, D. A.; Wellhausen, N.; Greenplate, A. R.; Chilukuri, L.; Mathew, D.; Xu, C.; Herati, R. S.; Huang, A. C.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Synthetic lethality by targeting ribonucleotide reductase in PP2A deficient uterine serous carcinoma
    Meeting Abstract

    O'Connor, C. M.; Taylor, S. E.; Miller, K. M.; Hurst, L.; Haanen, T. J.; Suhan, T. K.; Zawacki, K. P.; Noto, F. K.; Trako, J.; Mohan, A.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Meeting Abstract

    Burman, B.; Ceglia, N.; Hirschhorn, D.; Budhu, S.; Mangarin, L.; Oseledchyk, A.; Bykov, Y.; McPherson, A.; Shah, S.; Wolchok, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
    Meeting Abstract

    Vázquez-García, I.; Uhlitz, F.; Ceglia, N.; Lim, J. L.; Wu, M.; Mohibullah, N.; Ruiz, A. E. B.; Boehm, K. M.; Bojilova, V.; Fong, C. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic instability as a determinant of immune escape in ovarian cancer
    Meeting Abstract

    Vazquez-Garcia, I.; Uhlitz, F.; Ceglia, N.; Lim, J.; Wu, M.; Mohibullah, N.; Niyazov, J.; Ruiz, A. E.; Soslow, R.; Ellenson, L.; more...
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Exploiting SMARCA2 dependency for targeted therapy in SMARCA4-deficient ovarian cancers
    Meeting Abstract

    Brodeur, M.; Dopeso, H.; Green, H.; Ito, K.; Hulse, M.; Brown, J.; Weigelt, B.; Zamarin, D.
    International Journal of Gynecological Cancer (2022)

    Fulltext@MSK | Save
  • Endogenous retrotransposable elements induction in SMARCA4-deficient ovarian cancer is associated with immunomodulatory changes in the tumor microenvironment
    Meeting Abstract

    Brodeur, M. N.; Sun, S.; Zhu, Y.; Greenbaum, B.; Weigelt, B.; Zamarin, D.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • What matters most in FIGO IIIA endometrial cancer: Involvement of serosa, adnexa, or both?
    Meeting Abstract

    Rios-Doria, E.; Abu-Rustum, N.; Glaser, G.; McGree, M.; Eriksson, A. G. Z.; Pham, M.; Soliman, P.; Ataseven, B.; Alektiar, K.; Zamarin, D.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save